- •DEDICATION
- •PREFACE
- •CONTRIBUTORS
- •INSTRUCTIONS TO USERS
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •generic name: Zidovudine.
- •Primary use
- •Ocular side effects
- •Systemic administration (oral or intravenous)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Amebicides
- •generic names: 1. Broxyquinoline; 2. diiodohydroxyquinoline (iodoquinol).
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Emetine hydrochloride.
- •Primary use
- •Ocular side effects
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Anthelmintics
- •generic name: Diethylcarbamazine citrate.
- •Primary use
- •Ocular side effects
- •Local ophthalmic use or exposure – topical application
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Mepacrine hydrochloride.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Inadvertent direct ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Piperazine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Thiabendazole.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: AntibiOtics
- •generic name: Amikacin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Bacitracin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Inadvertent orbital injection (ointment)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Chloramphenicol.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Local ophthalmic use or exposure – intracameral injection
- •systemic side effects
- •Local ophthalmic use or exposure
- •clinical significance
- •Recommendations for topical ocular chloramphenicol
- •REFERENCES AND FURTHER READING
- •generic name: Ciprofloxacin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Systemic reactions from topical ocular medication
- •Conditional/Unclassified
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Demeclocycline; 2. doxycycline; 3. minocycline; 4. oxytetracycline; 5. tetracycline.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: filgrastim.
- •Primary use
- •Ocular side effect
- •Systemic administration – intravenous
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Systemic reactions from topical ocular medication
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Gentamicin sulfate.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Local ophthalmic use or exposure – intravitreal or intraocular injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Kanamycin sulfate.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – subconjunctival injection
- •REFERENCES AND FURTHER READING
- •generic name: Linezolid.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •generic name: Nalidixic acid.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Neomycin.
- •Primary use
- •Ocular side effects
- •Systemic administration (neomycin powder to mucus membranes)
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Nitrofurantoin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Polymyxin B sulfate.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Sulfacetamide; 2. sulfafurazole (sulfisoxazole); 3. sulfamethizole; 4. sulfamethoxazole; 5. sulfanilamide; 6. sulfasalazine; 7. sulfathiazole.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Conditional/Unclassified
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Telithromycin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Probable
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Tobramycin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Inadvertent ocular exposure – intraocular injection
- •Inadvertent ocular exposure – subconjunctival injection
- •Inadvertent ocular exposure – ointment in anterior chamber
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Antifungal Agents
- •generic name: Amphotericin B.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Local ophthalmic use or exposure – intracameral injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Griseofulvin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES
- •Class: Antileprosy Agents
- •generic name: Clofazimine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Dapsone.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Chloroquine; 2. hydroxychloroquine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations for hydroxychloroquine
- •Recommendations for chloroquine
- •caution
- •REFERENCES AND FURTHER READING
- •generic name: Mefloquine hydrochloride.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Quinine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Antiprotozoal Agents
- •generic name: Metronidazole.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Suramin sodium.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Tryparsamide.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Antitubercular Agents
- •generic name: Cycloserine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Ethambutol.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •generic name: Ethionamide.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Isoniazid.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Rifabutin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Rifampicin.
- •Primary use
- •Systemic
- •Ophthalmic
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure (ointment)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Thioacetazone (Amithiozone).
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Analeptics
- •generic name: Gabapentin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Lamotrigine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Vigabatrin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Benzfetamine hydrochloride; 2. amfepramone hydrochloride (diethylpropion); 3. phendimetrazine tartrate; 4. phentermine.
- •REFERENCES AND FURTHER READING
- •class: antianxiety agents
- •Generic names: 1. Alprazolam; 2. chlordiazepoxide; 3. clonazepam; 4. clorazepate dipotassium; 5. diazepam; 6. flurazepam; 7. lorazepam; 8. midazolam; 9. oxazepam; 10. temazepam; 11. triazolam.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Carisoprodol; 2. meprobamate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: anticonvulsants
- •Generic names: 1. Ethosuximide; 2. methsuximide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ethotoin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Phenytoin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects (fetal hydantoin syndrome)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Sodium valproate; 2. valproate semisodium; 3. valproic acid.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Topiramate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •Recommendations (Fraunfelder, Fraunfelder and Keates)
- •REFERENCES AND FURTHER READING
- •Generic name: Zonisamide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: antidepressants
- •Generic names: 1. Amitriptyline; 2. desipramine hydrochloride; 3. nortriptyline hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Amoxapine; 2. clomipramine hydrochloride; 3. doxepin hydrochloride; 4. trimipramine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Carbamazepine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Citalopram hydrobromide; 2. fluoxetine hydrochloride; 3. fluvoxamine maleate; 4. paroxetine hydrochloride; 5. sertaline.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Isocarboxazid; 2. phenelzine; 3. tranylcypromine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: Maprotiline.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Methylphenidate hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration – oral
- •Systemic administration – intravenous
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Trazodone.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: antipsycHotic agents
- •Generic names: 1. Chlorpromazine; 2. fluphenazine; 3. perphenazine; 4. prochlorperazine; 5. promethazine; 6. thiethylperazine; 7. thioridazine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Droperidol; 2. haloperidol.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Lithium carbonate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Loxapine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Pimozide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Quetiapine fumarate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names: Tiotixene.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Psychedelic agents
- •Generic names: 1. Dronabinol (tetrahydrocannabinol, THC); 2. hashish; 3. marihuana (marijuana).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Lysergic acid diethylamide (LSD), lysergide; 2. mescaline; 3. psilocybin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Topical ocular application – liquid LSD
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Phencyclidine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Sedatives and Hypnotics
- •Generic names: 1. Amobarbital; 2. butalbital; 3. methohexital; 4. methylphenobarbital (mephobarbital); 5. pentobarbital; 6. phenobarbital; 7. primidone; 8. secbutabarbital; 9. secobarbital.
- •Primary use
- •ocular side effects
- •Systemic administration (Primarily excessive dosage or chronic use)
- •Ocular teratogenic effects (primidone)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Chloral hydrate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: agents used to treat gout
- •Generic name: Allopurinol.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name: Colchicine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: antirheumatic agents
- •Generic name: 1. Adalimumab; 2. etanercept; 3. infliximab.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Auranofin; 2. aurothioglucose; 3. sodium aurothiomalate (gold sodium thiomalate).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Celecoxib; 2. etolodac; 3. nimesulide; 4. rofecoxib; 5. valdecoxib.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Fenoprofen calcium.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Flurbiprofen.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ibuprofen.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Indometacin (indomethacin).
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure - topical ocular
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ketoprofen.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: naproxen.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Piroxicam.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Mild analgesics
- •Generic names: Aspirin (acetylsalicylic acid).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Codeine; 2. dextropropoxyphene.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: Paracetamol (acetaminophen).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Possible
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: narcotic antagonists
- •Generic names: 1. naloxone hydrochloride; 2. naltrexone.
- •Primary use
- •ocular side effects
- •Local ophthalmic use or exposure (naloxone)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Strong analgesics
- •Generic name: Diacetylmorphine (diamorphine, heroin).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Hydromorphone hydrochloride (dihydromorphinone); 2. oxymorphone hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Methadone hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Morphine; 2. opium.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – morphine
- •Epidural or intravenous exposure
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Pethidine hydrochloride (meperidine).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Pentazocine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: adjuncts to anesthesia
- •Generic name: Hyaluronidase.
- •Primary use
- •ocular side effects
- •Subconjunctival or retrobulbar injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Hyoscine (scopolamine); 2. hyoscine methobromide (methscopolamine).
- •Primary use
- •Systemic
- •Topical
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Local ophthalmic use or exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Suxamethonium chloride (succinylcholine).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations for use in open globe (after chidiac 2004)
- •REFERENCES AND FURTHER READING
- •class: General anesthesia
- •Generic name: Ether (anesthetic ether).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ketamine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Methoxyflurane.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: nitrous oxide.
- •Primary use
- •ocular side effects.
- •Systemic administration
- •Intravitreal injection of gas during vitrectomy
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Propofol.
- •Primary use
- •ocular side effects
- •Intravenous administration
- •Accidental ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: local anesthetics
- •Generic names: 1. Bupivacaine hydrochloride; 2. chloroprocaine hydrochloride; 3. lidocaine; 4. mepivacaine hydrochloride; 5. prilocaine; 6. procaine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration – spiral, caudal, epidural, extradural injections
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: tHerapeutic Gases
- •Generic name: Carbon dioxide.
- •Primary use
- •ocular side effects
- •Systemic administration – extreme concentrations
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: Oxygen, oxygen-ozone.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: agents used to treat acid Peptic disorders
- •Generic names: 1. Cimetidine; 2. famotidine; 3. nizatidine; 4. ranitidine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •generic names: 1. Ergometrine maleate (ergonovine); 2. ergotamine tartrate; 3. methylergometrine maleate (methylergonovine).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: antianginal agents
- •generic name: 1. Amyl nitrite; 2. butyl nitrite.
- •Primary use
- •ocular side effects
- •Inhalation administration
- •Topical ocular application – inadvertent contact with liquid
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Diltiazem hydrochloride; 2. nifedipine; 3. verapamil hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •generic names: 1. flecainide acetate; 2. procainamide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: nitroglycerin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: antiarrythmic agents
- •generic name: Amiodarone.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •recommendations
- •REFERENCES AND FURTHER READING
- •generic name: Disopyramide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Methacholine chloride.
- •Primary use
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: 1. Oxprenolol hydrochloride; 2. propranolol hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Quinidine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: antihypertensive agents
- •generic names: 1. Acebutolol; 2. atenolol; 3. carvedilol; 4. labetolol hydrochloride; 5. metoprolol; 6. nadolol; 7. pindolol.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: 1. Alfuzosin hydrochloride; 2. doxazosin; 3. tamsulosin; 4. terazosin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Captopril; 2. enalapril.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Clonidine.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Diazoxide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Guanethidine monosulfate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Hydralazine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Minoxidil.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Topical application
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Prazosin hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Rescinnamine; 2. reserpine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: BronChodilators
- •generic name: Ipratropium.
- •Primary use
- •ocular side effects
- •Systemic administration – solution, aerosols or nasal sprays
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Salbutamol (albuterol).
- •Primary use
- •ocular side effects
- •Systemic administration – nebulizer
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: diuretics
- •generic names: 1. Bendroflumethiazide; 2. chlorothiazide; 3. chlortalidone; 4. hydrochlorothiazide; 5. hydroflumethiazide; 6. indapamide; 7. methyclothiazide; 8. metolazone; 9. polythiazide; 10. trichlormethiazide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: furosemide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Osmotics
- •generic name: Glycerol (glycerin).
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Mannitol.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Peripheral Vasodilators
- •generic name: Phenoxybenzamine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Vasopressors
- •generic name: Ephedrine.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: 1. Epinephrine; 2. norepinephrine (levaterenol).
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration – injection
- •Local ophthalmic use or exposure
- •Systemic side effects
- •Local ophthalmic use or exposure – epinephrine
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Phenylephrine.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration – nasal application
- •Local ophthalmic use or exposure
- •Systemic side effects
- •Local ophthalmic use or exposure
- •Conditional/Unclassified
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Intraocular injection
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Systemic
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration (toxic levels)
- •Inadvertent ocular exposure
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Intrathecal and intraventricular injections
- •Intracameral injection
- •Local ophthalmic use or exposure
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration – intravenous injections
- •Intracrameral injections
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Local ophthalmic use or exposure – subconjunctival injection
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration – intravenous
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Ocular teratogenic effects
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration – oral
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Class: Antihistamines
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Ocular side effects
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Local ophthalmic use or exposure – mitomycin
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •Ocular teratogenic effects
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration – intraveneous
- •Systemic administration – intracarotid injection
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration
- •Local ophthalmic use or exposure
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •REFERENCES AND FURTHER READING
- •Systemic administration – intracarotid injection
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration
- •Injection into the eyelid (fluorouracil)
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration (intramuscular, subcutaneous or intravenous injections)
- •REFERENCES AND FURTHER READING
- •Ocular side effects
- •Systemic administration (interleukin 2)
- •Subcutaneous administration (interleukin 3 and 6)
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Ocular teratogenic effects
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration (intravenous, intramuscular)
- •Local ophthalmic use or exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration (vincristine unless stated)
- •Inadvertent ocular exposure – vinblastine
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFEREnCEs AnD FuRTHER READInG
- •Chemical-induced ocular side effects
- •Class: acids
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Hydrofluoric acid
- •Hydrochloric acid
- •Sulfuric acid
- •Ocular side effects
- •Direct ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Aerosols
- •Generic names:
- •synonyms:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Defective or improper delivery – powder form of CS and CN
- •systemic side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •Proprietary name:
- •Primary use
- •Ocular side effects
- •Systemic administration – acute intoxication
- •Systemic administration – chronic intoxication
- •Ocular teratogenic effects (fetal alcohol syndrome)
- •Local ophthalmic use or exposure – retrobulbar injection
- •Inadvertent ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Alkali
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical Ocular Exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Bleaches
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Detergents
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Glues
- •Generic name:
- •synonyms:
- •Proprietary names:
- •Primary use
- •Ocular side effects
- •Topical Ocular Exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Herbicides and insecticides
- •Generic name:
- •synonyms:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Systemic exposure – acute effects
- •Systemic exposure – chronic effects
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Hydrocarbons
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: MisCellaneOus
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Herbal medicine and dietary supplement induced ocular side effects
- •Herbal or supplement name: Canthaxanthine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Datura.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Ginkgo biloba.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Licorice.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Retinol (Vitamin A).
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FuRTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
effects side ocular induced-Chemical • 8 PART
References and Further Reading
American Association of Poison Control Centers Toxic Exposure Surveillance System database, 2002–2005, Human ocular exposures by substance. Data pull 8/23/06.
Brahma AK, Inkster C. Alkaline chemical ocular injury from Emla cream. Eye 9(Pt 5): 658–659, 1995.
Brodovsky SC, McCarty CA, Snibson G, et al. Management of alkali burns: an 11-year retrospective review. Ophthalmology 107: 1829–1835, 2000.
Corazza M, Trincone S, Virgili A. Effects of airbag deployment: lesions, epidemiology, and management. Am J Clin Dermatol 5: 295–300, 2004.
Davis AR, Ali QK, Aclimnados WA, Hunter PA. Topical steroid use in the treatment of ocular alkali burns. Br J Ophthalmol 81: 732–734, 1997.
He J, Bazan NG, Bazan HE. Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist. Arch Ophthalmol 124: 70–78, 2006.
Ikeda N, Hayasaka S, Hayasaka Y, Watanabe K. Alkali burns of the eye: effect of immediate copious irrigation with tap water on their severity. Ophthalmologica 220: 225–228, 2006.
Kompa S, Schareck B, Tympner J, et al. Comparison of emergency eye-wash products in burned porcine eyes. Graefes Arch Clin Exp Ophthalmol 240: 308–313, 2002.
Kuckelkorn R, Schrage N, Keller G, Redbrake C. Emergency treatment of chemical and thermal eye burns. Acta Ophthalmol Scand 80: 4–10, 2002.
Laria C, Alio JL, Ruiz-Moreno JM. Combined non-steroidal therapy in experimental corneal injury. Ophthalmic Res 29: 145–153, 1997.
Merle H, Donnio A, Ayeboua L, et al. Alkali ocular burns in Martinique (French West Indies). Evaluation of the use of an amphoteric solution as the rinsing product. Burns 31: 205–211, 2005.
Schrage NF, Kompa S, Haller W, Langefeld S. Use of an amphoteric lavage solution for emergency treatment of eye burns. First animal type experimental clinical considerations. Burns 28: 782–786, 2002.
Sekundo W, Augustin AJ, Strempel I. Topical allopurinol or corticosteroids and acetylcysteine in the early treatment of experimental corneal alkali burns: a pilot study. Eur J Ophthalmol 12: 366–372, 2002.
Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 41: 275–313, 1997.
Wagoner MD, Kenyon KR. Chemical injuries of the eye. In: Albert DM, Jacobiec FA, eds Principles and Practice of Ophthalmology, 2nd edn. WB Saunders, Philadelphia, 2000.
Clinical significance
Boric acid dust has been reported as an ocular irritant in industrial exposures although it is generally considered non-toxic to the eyes. In low concentrations, it has historically been used as an eye wash. In a private data pull, the American Association of Poison Control Centers Toxic Exposure Surveillance System database recorded a low incidence of ocular injury from 2001–2005, but there were two reports of ocular injury rated as ‘major’ (indicating some type of significant residual disability) and 10 reports of injury rated as ‘moderate’ (indicating an injury with prolonged symptoms requiring treatment but not resulting in permanent injury). However, this data does not detail the nature of the injuries reported or their treatment.
Recommendations
Standard irrigation with sterile water or isotonic saline is recommended for ocular exposure to boric acid dust. As boric acid and borax are usually present in the form of soaps and cleansers, most exposures to these substances will coincide with exposures to surfactants. See the section on surfactants for how to treat these injuries.
References and Further Reading
American Association of Poison Control Centers Toxic Exposure Surveillance System database, 2002–2005, human ocular exposures by substance. Data pull 8/23/06.
Garabrant DH, Bernstein L, Peters JM, Smith TJ. Respiratory and eye irritation from boron oxide and boric acid dusts. J Occup Med 26: 585–6. 1984.
Generic name: Chlorine
Synonyms: Bleach, chlorine gas, sodium hypochlorite, calcium hypochlorite; hypochlorous acid, chloramines, chlorinated isocyanurates, chlorinated hydantoins, chlorinated lime, chlorine dioxide, tosylchloramide sodium, sodium oxychloride.
Proprietary names/products containing: Found in
a variety of household and commercial cleaners.
Class: Bleaches
Generic name: Boric acid.
Synonyms: Orthoboric acid; boracic acid.
Proprietary names/products containing: In a vari-
ety of household laundry detergents, hand soaps and lotions.
Primary use
Borax (or sodium tetraborate) is a naturally occurring alkaline compound that is a precursor in the manufacture of boric acid. Used as a preservative, buffer, antiseptic and fungicide, boric acid is also used to manufacture glazes and enamels, and to fireproof textiles and wood. In the household, boric acid and borates as tablets or powder are used to kill insects. It is a frequent ingredient in soaps and detergents. It is used in conjunction with borax to buffer and preserve certain eye drops.
Ocular side effects
Topical ocular exposure
Certain
1. Irritation
Primary use
A halogen gas, chlorine is also available as a pressurized solution. There are many more stable compounds that release chlorine in the form of hypochlorous acid and hypochlorite ion when exposed to water. When otherwise stable chlorine-releasing compounds are combined with acids, chlorine gas may be liberated, and when combined with ammonia, poisonous chloramines may be released.
The ability of chlorine gas or the non-ionized hypochlorous acid molecule to chlorinate proteins yields its extreme effectiveness in disinfection. Chlorine gas is used to sanitize public water supplies. Various chlorine compounds are used to disinfect swimming pools. In medical clinics, bleach (sodium hypochlorite 5-10%) is commonly used as a surface disinfectant, including the disinfection of applanation tonometer tips.
Ocular side effects
Topical ocular exposure
Certain
1. Irritation
2. Cornea
a.Edema
b.Punctate epithelial erosions 3. Conjunctiva – hyperemia
298
